All In MedTech

Device Trial Radar · NCT05736848

A Retrospective Assessment of OviTex PRS (OviTex)

A Retrospective Assessment of OviTex PRS (OviTex) Permanent and Resorbable Devices in Subjects Who Have Previously Undergone a Breast Reconstruction

Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Sep 27, 2022

Primary completion

Aug 30, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Tela Bio IncNot on our public-company list
Sponsor type
Industry
Collaborators
MCRA
First posted
Feb 21, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 75 years

Summary

As written by the sponsor on the registry.

The objective of this retrospective-prospective, observational study is to evaluate the safety profile overall and within two device types of OviTex PRS in previous pre-pectoral or sub-pectoral implant-based breast reconstructions.

Conditions

  • Reconstructive Surgical Procedures

Interventions

  • OviTex® PRSDevice

    OviTex® PRS is a reinforced tissue matrix intended to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The occurrence of relevant (S)AEs within 24 months of OviTex® PRS implantation.Time frame: 24 months

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Aesthetic Surgery Center

    Naples, Florida

  • Castrellon Aesthetic Surgery

    South Miami, Florida

  • Y Plastic Surgery

    Alpharetta, Georgia

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.